SCHEMBL6301196

SCHEMBL6301196

CC(=O)OCC=Cc1cnc2ccccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
KMT2A Q03164 2/20 0.60
RAB9A P51151 5/20 0.58
PDGFRB P09619 2/20 0.54
PDGFRA P16234 2/20 0.54
ALDH1A1 P00352 5/20 0.47
NPC1 O15118 2/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 3/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MGAM O43451 1/20 0.43
MAP4K4 O95819 1/20 0.42
CSNK1G2 P78368 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
MAP4K5 Q9Y4K4 1/20 0.42
NOTUM Q6P988 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301193 1.00 KDM4E (0.60) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL6378320 0.84 KDM4E (0.54) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL371965 0.84 KDM4E (0.54) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL372483 0.84 KDM4E (0.54) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL7738389 0.82 KMT2A (0.52) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL14158089 0.81 PDGFRB (0.61) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL17461321 0.81 PDGFRB (0.61) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB
SCHEMBL9997162 0.80 PTGS1 (0.49) MAPTPPARA
SCHEMBL7649080 0.80 PTGS1 (0.49) MAPTPPARA
SCHEMBL13699174 0.79 PDGFRB (0.58) KDM4ESMN1; SMN2KMT2ARAB9APDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933283-B2 11-deoxy azalide antibacterials ABBOTT LABORATORIES (US) 2005-08-23 US disclosed
US-20040014953-A1 11-Deoxy azalide antibacterials ABBVIE INC. 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014953-A1 11-Deoxy azalide antibacterials TOP1, TOP2B, TOP2A KDM4E 1238/4885SMN1; SMN2 780/4885KMT2A 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.